CAMBRIDGE, Mass.--(BUSINESS WIRE)--OvaScienceSM (NASDAQ: OVAS), a global fertility company focused on the discovery, development and commercialization of new treatment options, announced today that in vitro fertilization (IVF) specialists from select international clinics will present initial clinical experience with OvaScience’s AUGMENTSM fertility treatment during the Society for Reproductive Investigation (SRI) 62nd Annual Scientific Meeting March 25-28, 2015 in San Francisco, CA.
Help employers find you! Check out all the jobs and post your resume.
